Matthew Partin

Matthew Partin is a Senior Manager in External Manufacturing at Intellia Therapeutics, Inc., with extensive experience in the biotechnology and pharmaceutical industries. Previously at Biogen for nearly two decades, Partin held various roles including Senior Manager for Clinical External Manufacturing focused on gene therapy and Manager for Global External Manufacturing overseeing finished goods production. Partin's career also includes significant responsibilities in quality assurance and operations, alongside a background in quality control chemistry. Partin began professional tenure at Bayer Pharmaceuticals as a QC Chemistry Analyst and also contributed to athletic coaching at Southside Christian School. Matthew Partin earned a Bachelor of Science in Textile Chemistry from North Carolina State University.